Adult-type granulosa cell tumors and FOXL2 mutation

Cancer Research

Volumn 69, Issue 24, 2009, Pages 9160-9162

  Köbel, Martin ^a   Gilks, C Blake ^b   Huntsman, David G ^c  

^a UNIVERSITY OF CALGARY   (Canada)

^b VANCOUVER GENERAL HOSPITAL   (Canada)

^c BRITISH COLUMBIA CANCER AGENCY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR FOXL2; UNCLASSIFIED DRUG;

CARCINOGENESIS; FOXL2 GENE; GENE; GENE MUTATION; GRANULOSA CELL TUMOR; HISTOPATHOLOGY; HUMAN; NUCLEIC ACID BASE SUBSTITUTION; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVIEW;

ADULT; FEMALE; FORKHEAD TRANSCRIPTION FACTORS; GRANULOSA CELL TUMOR; HUMANS; OVARIAN NEOPLASMS;

EID: 73649091480     PISSN: 00085472     EISSN: 15387445     Source Type: Journal    
DOI: 10.1158/0008-5472.CAN-09-2669     Document Type: Review

References (16)

1. Schumer ST, Cannistra SA. Granulosa cell tumor of the ovary. J Clin Oncol 2003;21:1180-9.
2. Fuller PJ, Chu S. Signalling pathways in the molecular pathogenesis of ovarian granulosa cell tumours. Trends Endocrinol Metab 2004;15:122-8.
3. Kalfa N, Ecochard A, Patte C, et al. Activating mutations of the stimulatory g protein in juvenile ovarian granulosa cell tumors: a new prognostic factor? J Clin Endocrinol Metab 2006;91:1842-7.
4. Lappohn RE, Burger HG, Bouma J, et al. Inhibin as a marker for granulosa-cell tumors. N Engl J Med 1989; 321:790-3.
5. Shah SP, Kobel M, Senz J, et al. Mutation of FOXL2 in granulosa-cell tumors of the ovary. N Engl J Med 2009; 360:2719-9.
6. Zhao C, Vinh TN, McManus K, et al. Identification of the most sensitive and robust immunohistochemical markers in different categories of ovarian sex cord-stromal tumors. Am J Surg Pathol 2009;33: 354-66.
7. Lack EE, Perez-Atayde AR, Murthy AS, et al. Granulosa theca cell tumors in premenarchal girls: a clinical and pathologic study of ten cases. Cancer 1981;48:1846-4.
8. Kalfa N, Philibert P, Patte C, et al. Extinction of FOXL2 expression in aggressive ovarian granulosa cell tumors in children. Fertil Steril 2007;87:896-901.
9. Dorward AM, Shultz KL, Horton LG, et al. Distal Chr 4 harbors a genetic locus (Gct1) fundamental for spontaneous ovarian granulosa cell tumorigenesis in a mouse model. Cancer Res 2005;65:1259-64.
10. Cocque J, Pailhoux E, Jaubert F, et al. Evolution and expression of FOXL2. J Med Genet 2002;39:916-1.
11. Crisponi L, Deiana M, Loi A, et al. The putative forkhead transcription factor FOXL2 is mutated in blepharophimosis/ptosis/epicanthus inversus syndrome. Nat Genet 2001;27:159-6.
12. Schmidt D, Ovitt CE, Anlag K, et al. The murine winged-helix transcription factor Foxl2 is required for granulosa cell differentiation and ovary maintenance. Development 2004;131:933-42.
13. Beysen D, De Paepe A, De Baere E. FOXL2 mutations and genomic rearrangements in BPES. Hum Mutat 2009;30:158-69.
14. Ellsworth BS, Burns AT, Escudero KW, Duval DL, Nelson SE, Clay CM. The gonadotropin releasing hormone (GnRH) receptor activating sequence (GRAS) is a composite regulatory element that interacts with multiple classes of transcription factors including Smads, AP-1 and a forkhead DNA binding protein. Mol Cell Endocrinol 2003;206:93-111.
15. Pannetier M, Fabre S, Batista F, et al. FOXL2 activates P450 aromatase gene transcription: toward a better characterization of the early steps of mammalian ovarian development. J Mol Endocrinol 2006;36: 399-413.
16. Chen X, Rubock MJ, Whitman M. A transcriptional partner for MAD proteins in TGF-β signalling. Nature 1996;383:691-6.